Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RYTM
Stock Latest News
Company Announcements
Rhythm Pharmaceuticals Gains EMA Backing for IMCIVREE Expansion
7d ago
8K
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $105 from $100 at H.C. Wainwright
10d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals selects Pantherx Rare as pharmacy for Imcivree
13d ago
RYTM
Premium
Company Announcements
Rhythm Wins FDA Nod for Hypothalamic Obesity Therapy
13d ago
8K
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $149 from $139 at BofA
13d ago
RYTM
Premium
TipRanks Newswire
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)
13d ago
PTN
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $142 from $131 at Citi
13d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $155 from $152 at Citizens
13d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals trading resumes
14d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals trading halted, news pending
14d ago
RYTM
Premium
Ratings
Rhythm Pharmaceuticals: EMANATE Setback but Validated MC4R Mechanism and Pipeline Optionality Support Lowered $100 Buy Rating
15d ago
RYTM
Premium
The Fly
Rhythm price target lowered to $100 from $110 at H.C. Wainwright
15d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target lowered to $130 from $140 at RBC Capital
16d ago
RYTM
Premium
Ratings
Maintaining a Buy: Setmelanotide’s PDUFA Catalyst and Subgroup Signals Offset EMANATE Miss
16d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target lowered to $139 from $145 at BofA
16d ago
RYTM
Premium
Ratings
Maintained Buy on Rhythm Pharmaceuticals: EMANATE Setback Offset by Core Obesity Franchise and Pipeline Upside
16d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target lowered to $136 from $150 at Morgan Stanley
16d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target lowered to $131 from $136 at Citi
16d ago
RYTM
Premium
The Fly
Rhythm Pharmaceuticals price target lowered to $152 from $176 at Citizens
16d ago
RYTM
Premium
The Fly
Closing Bell Movers: Lensar down 24% on terminated Alcon deal
17d ago
AP
BW
Premium
Company Announcements
Rhythm Pharmaceuticals Reports Mixed Phase 3 EMANATE Results
17d ago
8K
RYTM
Premium
The Fly
Rhythm reports EMANATE trial substudies did not meet primary endpoints
17d ago
RYTM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
